Whole genome sequencing service allows for the detection of variants (structural, CNV, germline, somatic) in whole genome and for disease prediction in human. Discovering the genome origin and understanding any species can be possible through WGS.

Whole genome sequencing should not be confused with DNA profiling, which only determines the likelihood that genetic material came from a particular individual or group, and does not contain additional information on genetic relationships, origin or susceptibility to specific diseases.

We are providing highly efficient whole exome sequencing (WES) service to identify coding variants and rare variant mapping from the protein-coding regions in a genome or exome.

Changes to the DNA sequence called variants, may be harmful and can result in severe medical conditions. With WES sequencing, it is possible to identify variants that have been previously linked to specific genetic disorders and disease-associated genes by analyzing thousands of genes at the same time.

DNAGTx is providing targeted sequencing for researchers to identify specific subset of the genome to discover novel variants, customized sequencing panels and manageable data set.

Targeted sequencing panels can investigate a variety of disease areas and help in guiding therapy selection in clinical setting and support in-depth knowledge about one’s health.

Metagenomics enables research institutions and companies to explore the genetic diversity and functional potential of complex microbial populations without the need for cultivation. Analyzing metagenomic data requires specialized bioinformatics tools and expertise. GTX-Meta, from DNA-GTx Bioinformatics, provides comprehensive solutions to handle the computational and analytical challenges involved in processing and interpreting metagenomic datasets.